Navigating Late Line R/R Multiple Myeloma: Treatment Landscape, Patient Care, and Quality of Life - Episode 1

What is Late-Line RRMM and How is it Determined?

March 14, 2025
Saad Usmani, MD

,
Amrita Krishnan, MD

Panelists discuss how the term "late-line" in relapsed/refractory multiple myeloma typically refers to patients who have progressed through multiple previous treatment regimens, indicating a more advanced disease state that has become resistant to several standard therapeutic approaches.

Video content above is prompted by the following:

  • What does "late-line" relapsed/refractory multiple myeloma mean, and how is it determined that a patient is “late-line”?